Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Juan M Cardenas"'
Publikováno v:
SIAM Journal on Scientific Computing. 45:A200-A225
Many problems in computational science and engineering can be described in terms of approximating a smooth function of $d$ variables, defined over an unknown domain of interest $\Omega\subset \mathbb{R}^d$, from sample data. Here both the curse of di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b5f9787dcbb9691a046775953db7164
https://doi.org/10.1137/22m1472693
https://doi.org/10.1137/22m1472693
Publikováno v:
High-Dimensional Optimization and Probability ISBN: 9783031008313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ea4dcc8a190453279ad97c3e5901136
https://doi.org/10.1007/978-3-031-00832-0_2
https://doi.org/10.1007/978-3-031-00832-0_2
The problem of approximating smooth, multivariate functions from sample points arises in many applications in scientific computing, e.g., in computational Uncertainty Quantification (UQ) for science and engineering. In these applications, the target
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f398e6f1e3dd416216c5a0539bcb47
Autor:
Jayaprakash Kotha, Michelle Graham, Lisa K. Jennings, Stacie Lambert, Sridevi Kotha, Juan M Cardenas, Kinjal Hew
Publikováno v:
Cancer Research. 81:1308-1308
Introduction: GARP is a cell surface protein expressed post activation on regulatory T-cells (Treg), monocytes, B cells, and platelets. GARP binds to latent transforming growth factor beta (TGF-β1) and regulates the release of active TGF-β1. TGF-β
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b6fa1305cf5e82ff0fe7c78608491b2
https://doi.org/10.1158/1538-7445.am2021-1308
https://doi.org/10.1158/1538-7445.am2021-1308
Autor:
Lisa K. Jennings, Tristan Herve, Genmin Lu, Pamela B. Conley, Jayaprakash Kotha, Matthieu Bourdin, Juan M Cardenas
Publikováno v:
Blood. 136:37-38
Introduction: The anticoagulants rivaroxaban and apixaban inhibit Factor Xa (FXa) activity and are effective therapeutic agents for the prevention and treatment of thromboembolism. Andexanet alfa (andexanet) is the only specific reversal agent approv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c4f4864e807d7cbb4165fc8c748dfbb
https://doi.org/10.1182/blood-2020-140988
https://doi.org/10.1182/blood-2020-140988
Autor:
Ben Adcock, Juan M. Cardenas
In this paper, we address the problem of approximating a multivariate function defined on a general domain in $d$ dimensions from sample points. We consider weighted least-squares approximation in an arbitrary finite-dimensional space $P$ from indepe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ad73c78a5080b279ca51bec7597621c
http://arxiv.org/abs/1908.01249
http://arxiv.org/abs/1908.01249
Autor:
Gary R. Badger, Antonio D. Cardenas, Amy‐Kristina Herbert, Adrien L. Theriot, Laura Gomez, Chieh‐Ting Chang, Juan M. Cardenas Vasquez, Brett T. Chiquet
Publikováno v:
International journal of paediatric dentistry. 29(3)
BACKGROUND Parental preference for various behaviour management techniques (BMTs) used in paediatric dentistry has been shown to be influenced by many factors, including ethnicity. AIM To measure parental acceptability of BMTs used in paediatric dent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1aa04ae12348afd104aa33ae768a323
https://pubmed.ncbi.nlm.nih.gov/30618210
https://pubmed.ncbi.nlm.nih.gov/30618210
Autor:
Jay Vachhani, Susan Price, Andrei Belayev, Edward Hord, David M. Morris, Daniel Hoit, Christopher Nickele, Juan M Cardenas, Jayaprakash Kotha, Lisa K. Jennings, Vanessa Derrick, Adam S Arthur, Lucas Elijovich
Publikováno v:
Stroke. 49
Introduction: High rates of recanalization of Emergent Large Vessel Occlusion (ELVO) provide an opportunity to examine retrieved thrombi. We studied device and endothelial (ET) interactions to evaluate ET injury and the relationship between thrombi a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a79d2d8f6cc153069e179dc8a4ed318b
https://doi.org/10.1161/str.49.suppl_1.145
https://doi.org/10.1161/str.49.suppl_1.145
Autor:
Jayaprakash Kotha, Juan M Cardenas, Matthew T Roe, Erik M Ohman, Charles M Gibson, Lisa K Jennings
Publikováno v:
Circulation. 136
Introduction: Direct-acting oral anticoagulants (DOACs) are increasingly evaluated for the secondary prevention of thrombosis-related events; however, DOAC dose-related effects on platelet function, particularly with anti-platelet agents, are unknown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56298a275379a94f76391c996e08c745
https://doi.org/10.1161/circ.136.suppl_1.20955
https://doi.org/10.1161/circ.136.suppl_1.20955
Autor:
Michael J. Herr, Juan M Cardenas, Lisa K. Jennings, Genmin Lu, John T. Curnutte, Anjali Pandey, Jayaprakash Kotha, Pamela B. Conley
Publikováno v:
Circulation. 130
New oral fXa inhibitors have been increasingly adopted for VTE or AF treatment in the outpatient setting instead of warfarin. Andexanet alfa (AnXa) is a modified, recombinant human fXa molecule developed as a specific antidote to reverse anticoagulan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b07a634cd397a3eca9f31484a70c02f
https://doi.org/10.1161/circ.130.suppl_2.18218
https://doi.org/10.1161/circ.130.suppl_2.18218